Xinqun Li

2.8k total citations
33 papers, 2.0k citations indexed

About

Xinqun Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xinqun Li has authored 33 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Xinqun Li's work include Cancer, Hypoxia, and Metabolism (12 papers), Autophagy in Disease and Therapy (6 papers) and Ubiquitin and proteasome pathways (4 papers). Xinqun Li is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), Autophagy in Disease and Therapy (6 papers) and Ubiquitin and proteasome pathways (4 papers). Xinqun Li collaborates with scholars based in United States, China and United Kingdom. Xinqun Li's co-authors include Zhen Fan, Yang Lü, Tianhong Pan, Weidong Le, Ke Liang, Joseph Jankovic, Yun‐Cheng Wu, Wenjie Xie, Joseph Jankovic and Julie Zhu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Xinqun Li

33 papers receiving 2.0k citations

Peers

Xinqun Li
Elena Rapizzi Italy
Xingcong Ren United States
Theodoros Tsakiridis Canada
Laura Emionite Italy
Jiguang Ma China
Milica Momcilovic United States
Qinhong Xu China
Frank Weinberg United States
Qi Xie China
Shizuka Seino Japan
Elena Rapizzi Italy
Xinqun Li
Citations per year, relative to Xinqun Li Xinqun Li (= 1×) peers Elena Rapizzi

Countries citing papers authored by Xinqun Li

Since Specialization
Citations

This map shows the geographic impact of Xinqun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinqun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinqun Li more than expected).

Fields of papers citing papers by Xinqun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinqun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinqun Li. The network helps show where Xinqun Li may publish in the future.

Co-authorship network of co-authors of Xinqun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xinqun Li. A scholar is included among the top collaborators of Xinqun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinqun Li. Xinqun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xinyi, Xinqun Li, Guangju Zhao, & Wenming Xu. (2024). Neutrophil-lymphocyte ratio predict outcome of upper gastrointestinal bleeding in emergency. Frontiers in Medicine. 11. 1366715–1366715. 1 indexed citations
2.
Deng, Jenying, Ya’an Kang, Xinqun Li, et al.. (2021). DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. JCI Insight. 6(17). 89 indexed citations
3.
Dai, Bingbing, Jithesh J. Augustine, Ya’an Kang, et al.. (2021). Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. Cell Death and Disease. 12(7). 693–693. 7 indexed citations
4.
Lu, Haiquan, Yang Lü, Yangyiran Xie, et al.. (2019). Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma. JCI Insight. 4(19). 22 indexed citations
5.
Dai, Bingbing, David Roife, Ya’an Kang, et al.. (2017). Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 16(4). 662–670. 17 indexed citations
6.
Kang, Ya’an, David Roife, Yeon‐Ju Lee, et al.. (2016). Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Clinical Cancer Research. 22(19). 4934–4946. 29 indexed citations
7.
Roife, David, Bingbing Dai, Ya’an Kang, et al.. (2016). Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 22(24). 6021–6030. 46 indexed citations
8.
Lu, Haiquan, Xinqun Li, Yang Lü, Songbo Qiu, & Zhen Fan. (2016). ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis. Cancer Letters. 381(1). 23–30. 54 indexed citations
9.
Li, Xinqun, Ya’an Kang, Xavier Chopin‐Laly, et al.. (2014). Extracellular Lumican Inhibits Pancreatic Cancer Cell Growth and Is Associated with Prolonged Survival after Surgery. Clinical Cancer Research. 20(24). 6529–6540. 69 indexed citations
10.
Lu, Haiquan, Xinqun Li, Zhongguang Luo, Jie Liu, & Zhen Fan. (2013). Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A. Molecular Cancer Therapeutics. 12(10). 2187–2199. 69 indexed citations
11.
Wu, Yun‐Cheng, Xinqun Li, Julie Zhu, et al.. (2011). Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease. Neurosignals. 19(3). 163–174. 405 indexed citations
12.
Xu, Wen & Xinqun Li. (2011). Immunoproteomic analysis of the antibody response obtained in mouse following vaccination with a T‐cell vaccine. PROTEOMICS. 11(22). 4368–4375. 6 indexed citations
13.
Li, Xinqun, et al.. (2010). 1, 9-Pyrazoloanthrones Downregulate HIF-1α and Sensitize Cancer Cells to Cetuximab-Mediated Anti-EGFR Therapy. PLoS ONE. 5(12). e15823–e15823. 14 indexed citations
14.
Li, Xinqun, Yang Lü, Tianhong Pan, & Zhen Fan. (2010). Roles of autophagy in cetuximab-mediated cancer therapy against EGFR. Autophagy. 6(8). 1066–1077. 82 indexed citations
15.
Lü, Yang, Xinqun Li, Ke Liang, et al.. (2007). Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance to the anti-EGFR monoclonal antibody cetuximab. Cancer Research. 67. 4082–4082. 3 indexed citations
16.
17.
Li, Xinqun, Yang Lü, Weidong Jin, et al.. (2006). Autophosphorylation of Akt at Threonine 72 and Serine 246. Journal of Biological Chemistry. 281(19). 13837–13843. 28 indexed citations
18.
Li, Xinqun, Yang Lü, Ke Liang, Bolin Liu, & Zhen Fan. (2005). Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells. Breast Cancer Research. 7(5). R589–97. 88 indexed citations
19.
20.
Li, Xinqun. (2000). Local expression of interleukin-12 mRNA in grafted skin in rats. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Rapizzi Breakdown of academic impact, for papers by Xingcong Ren Breakdown of academic impact, for papers by Theodoros Tsakiridis Breakdown of academic impact, for papers by Laura Emionite Breakdown of academic impact, for papers by Jiguang Ma Breakdown of academic impact, for papers by Milica Momcilovic Breakdown of academic impact, for papers by Qinhong Xu Breakdown of academic impact, for papers by Frank Weinberg Breakdown of academic impact, for papers by Qi Xie Breakdown of academic impact, for papers by Shizuka Seino
Rankless by CCL
2026